Medtronic Care Management Services is launching two new software programs for assessing, monitoring and triaging people concerned about COVID-19 and potential symptoms. The MCMS COVID-19 virtual care evaluation and monitoring system — which Medtronic (NYSE:MDT) announced late last week — is now available to U.S. health systems, plans and employers. It follows the company’s launch of […]
DHS warns on Insulet Omnipod
The U.S. Dept. of Homeland Security (DHS) issued a medical advisory to warn of vulnerabilities with the Insulet (NSDQ:PODD) Omnipod insulin management system. According to the advisory, the affected insulin pumps are designed to communicate using a wireless RF with Insulet’s personal diabetes manager device, but the RF communication protocol does not properly implement authentication or […]
RaySearch Labs issues urgent field safety notice for certain RayStations
RaySearch Laboratories issued an urgent field safety notice in Europe to warn on an issue with the dose calculation for the Siemens (NYSE:SI) virtual wedge in several of RaySearch’s RayStation treatment planning systems. The affected RayStation models listed in the safety notice out of Germany included RayStation 4.0, RayStation 4.5, RayStation 4.7, RayStation 4.9 (RayPlan 1), […]
COVID-19 test development surges with pandemic
Companies around the world are racing to develop and distribute tests for COVID-19 to laboratories and to market other products and services they say can help patients and healthcare providers cope with the pandemic. On March 13, the FDA gave Thermo Fisher Scientific (NYSE:TMO) emergency use authorization (EUA) for a diagnostic test that certain U.S. laboratories […]
Nemaura Medical enters non-binding agreements for its SugarBeat platform
Nemaura Medical (NSDQ:NMRD) announced today that it entered into multiple verbal non-binding agreements for its SugarBeat continuous glucose monitor as it seeks to secure regional and global partnerships. The Loughborough, U.K.–based company expects the agreements to lead to discussions over licensing and collaboration, but can’t guarantee that deals will be struck as planned, or at all, […]
Nemaura Medical launches SugarBeat app
Nemaura Medical (NSDQ:NMRD) announced that it launched its SugarBeat app for continuous glucose monitoring on Android devices in the Play Store as it prepares to debut a subscription-based service. The Loughborough, England–based company’s SugarBeat is a non-invasive and flexible CGM designed to pair with BeatDiabetes, the company’s planned health subscription service for people with Type 2 […]
Companion Medical wins FDA nod for InPen diabetes management system
Companion Medical announced that it won FDA clearance for its InPen bolus calculator for fixed dosing and meal estimation in diabetes management. The new bolus calculator is designed to account for the user’s current glucose level and active insulin to remove the guesswork from insulin dosing. Companion Medical touts the system as the first of its […]
Iradimed appoints new VP of regulatory affairs and quality assurance
Iradimed (NSDQ:IRMD) this week said it appointed Steven Kachelmeyer as VP of regulatory affairs and quality assurance, effective March 10. Kachelmeyer will report directly to president and CEO Leslie McDonnell. He replaces Francis Casey who announced his intention to retire, effective June 30. “Under Fran’s leadership, Iradimed gained regulatory approvals in the U.S., Europe and many […]
PhysIQ touts VA study showing AI predicting hospitalizations
PhysIQ today is touting results from a study testing the ability to detect heart failure exacerbation using wearable sensors and personalized analytics based on artificial intelligence. The Link-HF study set out to assess the ability to predict rehospitalization due to heart failure exacerbation using analytics applied to continuous wearable sensor data, according to a news […]
Abbott touts real-world data around FreeStyle Libre system
Abbott (NYSE:ABT) recently announced that new real-world data shows that users of its FreeStyle Libre continuous glucose monitor (CGM) have improved on four different fronts. Users of the Abbott Park, Ill.–based company’s device showed better glucose control, increased time in target glucose range, decreased time in hyperglycemia and hypoglycemia and reduced HbA1C (average glucose levels over […]
BD touts cybersecurity cred of its microbiology informatics software
Becton Dickinson (NYSE:BDX) announced that its BD Synapsys microbiology informatics solution received certification from the Underwriters Laboratory Cybersecurity Assurance Program (UL CAP). UL CAP is an independent program that uses standardized, testable criteria to assess software vulnerabilities and weaknesses. BD touts its BD Synapsys software as one of the first life-science diagnostics informatics platforms to meet […]
- 1
- 2
- 3
- …
- 59
- Next Page »
